Viewing Study NCT01589094


Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2026-02-09 @ 2:22 AM
Study NCT ID: NCT01589094
Status: COMPLETED
Last Update Posted: 2019-10-02
First Post: 2012-04-27
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bladder Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CISPLATIN View
None GEMCITABINE View
None GM-CSF View
None radical cystectomy View
None 12-071 View